Evidence map›Paper›PMID 37900856›Full record

ArticleCase reports in oncology

First Female Patient with a Rare CIC-FOXO4-Translocated Sarcoma: A Case Report.

Aryeh Babkoff, Yael Berner-Wygoda, Judith Diment, Anatoli Kustanovich, Aviad Zick, Daniela Katz, Albert Grinshpun

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Molecular and therapeutic advancements in Capicua (Frontiers in cell and developmental biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aryeh BabkoffSharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Yael Berner-WygodaSharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Judith DimentFaculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Anatoli KustanovichSharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Aviad ZickSharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Daniela KatzFaculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Albert GrinshpunSharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small round cell sarcoma is a group of undifferentiated malignancies arising in the bone and soft tissue, notable for Ewing sarcoma. Recently, a new World Health Organization classification has been introduced, including an additional subset of these sarcomas, named CIC-rearranged sarcoma. Within this group, CIC-FOXO4 translocation is an exceedingly rare fusion that has been reported only 4 times in the literature. Herein, we report in-depth the pathological, clinical, and molecular features of a CIC-FOXO4 translocation-driven tumor in a 46-year-old woman.

Indexed as

CIC-FOXO4 translocationSmall round blue cell sarcomaTranscriptome

Identifiers

PMID37900856
PMCPMC10601800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.